Key facts
- This page summarizes Philip W. Kantoff's Form 4 filing for ESSA Pharma Inc. (EPIX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 28 Mar 2024, 12:34.
Philip W. Kantoff - 25 Mar 2024 Form 4 Insider Report for ESSA Pharma Inc. (EPIX)
- Reporting relationship
- Director
- Issuer ticker
- EPIX
- Reported as of
- 25 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 Mar 2024, 12:34:49 UTC
- Prior SEC filing
- 31 May 2023
- Next SEC filing
- 14 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Phil Kantoff
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Philip W. Kantoff filed Form 4 for ESSA Pharma Inc. (EPIX) on 28 Mar 2024.
Change
- Previous filing in this sequence was filed on 31 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EPIX
transaction
Derivative
Options
Award
- Transaction value
- $0
- Shares
- +50,000
- Change %
- Price
- $0.000000
- Shares after
- 50,000
- Date
- 25 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 50,000
- Exercise price
- $9.04
* marks a reported price that did not pass the local price check.